Dietary mistletoe lectin supplementation and reduced growth of a murine non-Hodgkin lymphoma

Histology and Histopathology

Volumn 17, Issue 1, 2002, Pages 261-271

  Pryme, Ian F ^a   Bardocz, S ^a   Pusztai, A ^a   Ewen, S W B ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Anti angiogenesis; Apoptosis; Lectin; Mistletoe; Non Hodgkin lymphoma; Peyer's patch

Indexed keywords

ANTINEOPLASTIC AGENT; KM 110; ML 2; ML 3; PHYTOHEMAGGLUTININ; UNCLASSIFIED DRUG; VISCUM ALBUM LECTIN;

ANGIOGENESIS; APOPTOSIS; CANCER CELL; CANCER GROWTH; CAPILLARY; CELL HYPERPLASIA; CELL NUCLEUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENDOCYTOSIS; FEEDING; HISTOLOGY; HUMAN; INCIDENCE; INOCULATION; LECTIN BINDING; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MICROSCOPY; MITOSIS; MORPHOLOGY; NONHODGKIN LYMPHOMA; NONHUMAN; PEYER PATCH; REVIEW; TUMOR BLOOD FLOW;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DIET; LYMPHOMA, NON-HODGKIN; MICE; MISTLETOE; PLANT PREPARATIONS; PLANT PROTEINS; TOXINS, BIOLOGICAL; TUMOR CELLS, CULTURED;

MURINAE; VISCUM; VISCUM ALBUM;

EID: 0036158802     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Mistletoe lectin activates caspace-8/FGLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis
2. Polyamines in tissue regeneration
3. Luminal and basolateral polyamine uptake by rat small intestine stimulated to grow by Phaseolus vulgaris lectin phytohaemagglutinin in vivo
4. Polyamine metabolism and uptake during Phaseolus vulgaris lectin, PHA-induced growth of the rat small intestine
5. Effect of phytohaemagglutinin on the growth of Krebs II tumour cells, body metabolism and internal organs of mice
6. Phytohaemagglutinin in the diet induces growth of the gut and modifies some organ weights in mice
7. Reversible effect of phytohaemagglutinin on the growth and metabolism of rat gastrointestinal tract
8. The effect of phytohaemagglutinin at differnt dietary concentrations on the growth, body composition and plasma insulin of the rat
9. Intracellular levels of polyamines in Krebs II lymphosarcoma cells in mice fed phytohaemagglutinin-containing diets are coupled with altered tumour growth
10. Uptake inter-organ distribution and metabolism of dietary polyamines in the rat
11. Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. I. Synergism with IL-2 in the induction of enhanced LAK cytotoxicity
12. Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations
13. Induction of mitochondrial Apo2.7 molecules and generation of reactive oxygen-intermediates in cultured lymphocytes by the toxic proteins from Viscum album L
14. Improved procedures for isolation of mistletoe claims and their subunits: Lectin pattern of the European mistletoe
15. Comparison of the effects of various clinically applied mistletoe preparations on peripheral blood leukocytes
16. Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model
17. The effects of PHA and mistletoe lectin binding to epithelium of rat and mouse gut
18. Does oral ingestion of ML-1 lectin ablate murine transplanted non-Hodgkin lymphoma by apoptosis or necrosis?
19. Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins
20. The galactoside-specific lectin from mistletoe as biological response modifier
21. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients
22. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract
23. Polyamine metabolism of enterocyte-like Caco-2 cells after exposure to Phaseolus vulgaris lectin
24. Celluluar and cytogenic approaches in testing toxic and safe concentrations of mistletoe lectins
25. American mistletoe exposures
26. Mucosal immunogenicity of plant lectins in mice
27. Efficiency of treatment with galactoside-specific lectin from mistletoe against rat glioma
28. Survival and glioma patients after complementary treatment with galactoside-specific lectin from mistletoe
29. Involvement of caspase-3 apoptosis induced by Viscum album var. colaratum agglutinin in HL-60 cells
30. Induction of tumour necrosis factor expression by a lectin from Viscum album
31. Antitumoral effects of an intravesically applied aqeous mistletoe extract on urinary bladder carcinoma in BM49 mice
32. Effects of mistletoe lectin I on human blood cell lines and peripheral blood cells. Cytotoxicity, apoptosis and induction of cytokines
33. Changes in organs and tissues induced by feeding of purified kidney bean (Phaseolus vulgaris) lectins
34. Protein kinase A or C modulates the apoptosis induced by lectin II isolated from Korean mistletoe, Viscum album var. Colaratum, in the human leukemic HL-60 cells
35. Potentiation of tumor necrosis factor-alpha-induced apoptosis and mistletoe lectin
36. Activation of c-Jun N-terminal kinase 1 (JNK1) in mistletoe lectin II-induced apoptosis of human myeloleukemic U937 cells
37. A diet containing the lectin phytohaemagglutinin (PHA) slows down the proliferation of Krebs II cell tumours in mice
38. The initial growth rate of Krebs II ascites cell tumours in mice is slowed down by the inclusion of phytohaemagglutinin in the diet
39. Switching between control and phytohaemagglutinin-containing diets affects growth of Krebs II ascites cells and produces differences in the levels of putrescine, spermidine and spermine
40. Inclusion of the plant lectin phytohaemagglutinin in the diet and its effects on development of murine tumours
41. The plant lectin PHA as a tool for reducing the progression of tumour growth
42. Phytohaemagglutinin induced gut hyperplasia and the growth of a mouse lymphosarcoma tumour
43. Dietary phytohaemagglutinin slows down the proliferation of a mouse plasmacytoma (MPC-11) tumour in Balb/c mice
44. The plant lectins PHA and ML-1 suppress the growth of a lymphosarcoma tumour in mice
45. The induction of gut hyperplasia by phytohaemagglutinin in the diet and limitation of tumour growth
46. A combination of dietary protein depletion and PHA-induced gut growth reduce the mass of a murine non-Hodgkin lymphoma
47. The growth of an established murine non-Hodgkin lymphoma tumour is limited by switching to a phytohaemagglutinin-containing diet
48. Limiting the availability of polyamines for a developing tumour: An alternative approach to reducing tumour growth
49. The extent of PHA-induced gut hyperplasia is reduced by a developing murine non-Hodgkin lymphoma tumour
50. Dietary phytohaemagglutinin reduces growth of a murine non-Hodgkin lymphoma
51. Feeding mice the plant lectins PHA and ML-1 decreases tumour mass and mitotic activity, increases lymphocyte infiltration and induces necrosis of a murine non-Hodgkin lymphoma
52. Phaseolus vulgaris lectin induces growth and the uptake of polyamines by the rat small intestine in vivo
53. Relationship between survival and binding of plant lectins during small intestinal passage and their effectiveness as growth factors
54. Effects of an orally administered mistletoe (type-2 RIP) lectin on growth, body composition, small intestinal structure, and insulin levels in young rats
55. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins
56. Mistletoe therapy for human cancer: The role of the natural killer cells
57. Recombinant mistletoe lectin (rML) is successful in treating human ovarian cancer cells transplanted into severe combined immunodeficient (SCID) mice
58. Polyamine transport in mammalian cells. An update
59. Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract
60. Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy
61. Toxic proteins from European mistletoe (Viscum album L.): Increase of intracellular IL-4 but decrease of IFN-gamma in apoptotic cells
62. Intracellular expression of IL-4 and inhibition of IFN-gamma by extracts from European mistletoe is related to induction of apoptosis
63. Induction of apoptosis by mistletoe lectin 1 and its subunits. No evidence for cytoxic effects caused by isolated A- and B-chains
64. 2+](i), and induces cell death
65. Inhibitory effect of Korean mistletoe (Viscum album coloratum) extract on tumor angiogenesis and of hematogenous and non-hematogenous tumor cells in mice
66. Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumour metastasis is mediated by enhancement of NK cell activity
67. Lectins isolated from Korean mistletoe (Viscum album coloratum) induce apoptosis in tumour cells